Concepedia

Andrew J. Geall

AJ

Statistics

Publications

26

Citations

3.3K

H-Index

24

Active since

1998

Affiliations

Novartis (United States)(Current)

Novartis (Italy)

University of Bath

Tris Pharma (United States)

Canada's Michael Smith Genome Sciences Centre

Andrew J. Geall is an author at Novartis (United States) specializing in immunology, nucleic acid vaccines, and vaccinology.

ORCID

Publications per year

1998–2025

26

Publications

26

Nonviral delivery of self-amplifying RNA vaccines

Andrew J. Geall, Ayush Verma, Gillis R. Otten et al. · Proceedings of the National Academy of Sciences · 2012 · 667 citations · Full text

, , +17

A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

Luis A. Brito, Michelle Y. Chan, Christine A. Shaw et al. · Molecular Therapy · 2014 · 333 citations · Full text

, , +17

Rapidly produced SAM <sup>®</sup> vaccine against H7N9 influenza is immunogenic in mice

Armin Hekele, Sylvie Bertholet, Jacob Archer et al. · Emerging Microbes & Infections · 2013 · 222 citations · Full text

, , +17

Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design

Timothy Pepini, Anne-Marie Pulichino, Thomas Carsillo et al. · The Journal of Immunology · 2017 · 209 citations · Full text

, , +17

Self-Amplifying mRNA Vaccines

Luis A. Brito, Sushma Kommareddy, Domenico Maione et al. · Advances in genetics · 2014 · 193 citations

1–5 of 26